八億時空(688181.SH):目前北京的混晶產能已經達到年產200噸的水平
格隆匯8月10日丨八億時空(688181.SH)近期在接待機構投資者調研時表示,目前,北京的混晶產能已經達到年產200噸的水平,滿足當前混晶市場需求。由於公共衞生事件和物流等綜合因素影響,二期工程項目受到了一定影響,預計2023年12月完成整體項目建設。
公司混晶產能的釋放與市場需求相匹配,公司在北京總部擁有充足的混晶產能儲備及產能提升能力,隨着公司上虞電子材料基地的建設及後續投入使用,公司的單晶產能儲備能力也將進一步加大。同時公司也將根據實際情況選擇外採一些性價比更高的單晶產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.